Related Experiment Video
Updated: Apr 17, 2026
11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
8.1K
Pathway crosstalk analysis of non-small cell lung cancer based on microarray gene expression profiling
Chunyan Xing1, Ronghua Zhang, Jiyun Cui
1Department of Respiration, Jinan Central Hospital Affiliated to Shandong University, Jinan - China.
Tumori
|February 24, 2015
Summary
This study reveals key pathway crosstalk disruptions in lung cancer metastasis. Understanding these interactions, particularly involving the Wnt signaling pathway and adherens junction, can lead to new lung cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Lung cancer exhibits complex somatic mutation profiles, posing challenges in biological interpretation.
- Understanding the molecular mechanisms driving lung cancer metastasis is crucial for effective treatment.
Purpose of the Study:
- To investigate the role of pathway crosstalk in lung cancer cell metastasis.
- To analyze gene expression data to identify dysfunctional pathways and their interactions.
Main Methods:
- Utilized DNA microarray data (GSE10096) from the Gene Expression Omnibus database.
- Identified differentially expressed genes (DEGs) and performed KEGG pathway analysis.
- Examined pathway crosstalk dysfunction in low (M1) and high (M5) metastatic lung cancer cells.
Main Results:
- Identified 13,433 DEGs and 108 cancer-related signaling pathways.
- Found significant pathway crosstalk dysfunction between non-small cell lung cancer pathways and Wnt signaling (hsa04310) or adherens junction (hsa04520).
- Observed crosstalk dysfunction between adherens junction and cell cycle, Wnt signaling, TGF-beta, and Jak-STAT pathways.
Conclusions:
- Elucidates molecular mechanisms underlying lung cancer's metastatic potential.
- Highlights specific pathway crosstalk disruptions critical for metastasis.
- Provides a foundation for developing targeted lung cancer therapies.
